A strategic move or a ploy to arrest further shareholder wealth erosion?
08/07/24 -"The Grifols family and Brookfield have agreed to take Grifols private and should submit the bid in the coming weeks. This comes at an opportune time for the controlling shareholders since the shares ..."
Pages
56
Language
English
Published on
08/07/24
You may also be interested by these reports :
17/09/26
Although our estimates have increased by double digits, the target price has been raised at a lower rate due to Ipsen’s near- and mid-term risks. ...
15/09/26
At a time when Novartis and AstraZeneca nurse a run of late-stage R&D setbacks, GSK’s recent clinical trial successes for oncology candidates, ...
14/09/26
Since its July 2022 listing, Haleon (BUY; UK) has delivered a total return of just under 20%. Unexciting, but not for want of progress. Assembled ...
11/09/26
The recent R&D setbacks in cardiovascular and neuroscience areas have prompted us to revise our target price downwards. In the process, we have also ...